Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report
- PMID: 36644405
- PMCID: PMC9835840
- DOI: 10.3389/fped.2022.1015617
Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report
Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a newly identified clinical entity still not very well known in terms of epidemiology, pathogenesis, and long-term outcome. Pulmonary involvement with acute respiratory failure is an unusual life-threatening complication of MIS-C, often a reason for admission to the pediatric intensive care unit (PICU) and the use of mechanical ventilation. We present a case of a 7-year-old male patient, previously healthy, hospitalized for MIS-C, treated with intravenous immunoglobulins (IVIG), high dose methylprednisolone, and anakinra. After 2 days of the aforementioned therapy, the patient presented with hypoxia (SatO2: 85% in ambient air room) and breathing difficulties. A chest computed tomography (CT) scan showed the presence of multiple bilateral basal parenchymal thickening and small basal pleural effusion and an arterial blood gas analysis revealed severe hypoxia (PaO2/FiO2 ratio, 170 mmHg). Because of a worsening of respiratory distress, the patient was transferred to the PICU, where invasive mechanical ventilation and a continuous infusion of anakinra (12 mg/kg/day) were started. An echocardiogram was performed, which showed an increase in pulmonary pressure (40 mmHg) with normal heart ejection fraction (55%), and the hypothesis of pulmonary vasculitis involving the pulmonary arterioles was made. Therefore, therapy with sildenafil (0.15 mg/kg/day) was promptly set up, with an immediate improvement of the clinical picture of respiratory failure, reduction of pulmonary pressure (23 mmHg), and subsequent extubation at 36 h with a regular clinical course until discharge. As far as we know, our case represents the first report of pulmonary vasculitis in an MIS-C patient. The use of sildenafil and high-dose continuous anakinra may represent a rescue therapy in cases of MIS-C with pulmonary vasculitis or with difficulty in extubation, allowing a short-term hospitalization in intensive care and improving the long-term outcome in these patients.
Keywords: COVID-19; MIS-C; anakinra; children; multisystem inflammatory syndrome in children; pulmonary hypertension; pulmonary vasculitis; sildenafil.
© 2023 La Torre, Calabrese, Signorile, Bizzoco, Mastrorilli, Strippoli, Amato, Carella, Vairo, Giordano, Milella and Cardinale.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.Front Pediatr. 2022 Aug 18;10:942455. doi: 10.3389/fped.2022.942455. eCollection 2022. Front Pediatr. 2022. PMID: 36061383 Free PMC article.
-
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.JAMA. 2021 Mar 2;325(9):855-864. doi: 10.1001/jama.2021.0694. JAMA. 2021. PMID: 33523115 Free PMC article.
-
Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature.J Emerg Med. 2020 Nov;59(5):699-704. doi: 10.1016/j.jemermed.2020.09.008. Epub 2020 Oct 1. J Emerg Med. 2020. PMID: 33011038 Free PMC article. Review.
-
Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis.J Pediatr Intensive Care. 2020 Nov 19;11(1):1-12. doi: 10.1055/s-0040-1719173. eCollection 2022 Mar. J Pediatr Intensive Care. 2020. PMID: 35178272 Free PMC article. Review.
Cited by
-
A Clinical Case of Multisystem Inflammatory Syndrome After SARS-CoV-2 Infection Associated with Group A β-Hemolytic Streptococcus Coinfection and Venous Thrombosis in a Child with Congenital Thrombophilia.Curr Issues Mol Biol. 2025 May 7;47(5):334. doi: 10.3390/cimb47050334. Curr Issues Mol Biol. 2025. PMID: 40699733 Free PMC article.
-
Multi-Inflammatory Syndrome in Children (MIS-C) in 2023: Is It Time to Forget about It?Children (Basel). 2023 May 31;10(6):980. doi: 10.3390/children10060980. Children (Basel). 2023. PMID: 37371212 Free PMC article.
-
Incidence and Prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C) in Southern Italy.Children (Basel). 2023 Apr 23;10(5):766. doi: 10.3390/children10050766. Children (Basel). 2023. PMID: 37238314 Free PMC article.
-
Advancing multidisciplinary management of pediatric hyperinflammatory disorders.Front Pediatr. 2025 Apr 30;13:1553861. doi: 10.3389/fped.2025.1553861. eCollection 2025. Front Pediatr. 2025. PMID: 40370972 Free PMC article. Review.
References
-
- Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, et al. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J. (2021) 19(1):29. 10.1186/s12969-021-00511-7 - DOI - PMC - PubMed
-
- Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of rheumatology clinical guidance for multisystem infammatory syndrome in children associated with SARS-CoV-2 and hyperinfammation in pediatric COVID-19: version 1. Arthritis Rheumatol. (2020) 72(11):1791–805. 10.1002/art.41454 - DOI - PMC - PubMed
-
- Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol. (2021) 73(4):e13–29. 10.1002/art.41616 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials